table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
antiviral and associated therapy
azithromycin Sekhavati RECOVERY ... COALITION I Covid-19 Brazil ... Rashad A ...
azvudine Ren
baloxavir marboxil Lou Y
bromhexine Ansarin Tolouian Li T
chloroquine and derivatives
chloroquine Huang Chen, ChiCTR2000030054 - Chloroquine NCT04342650
hydroxychloroquine Tang HAHPS ORCHID Duke University hydroxychloroquine/azithromycine RECOVERY SOLIDARITY ... Chen NO COVID-19 ... Abd-Elsalam CCAP-1 Duke university HCQ ARCHAIC -hydroxychloroquine PROTECT B TEACH OAHU-COVID19 HYCOVID IRCT20200428047228N1 // U07 Gonzalez ... PROTECT A ChiCTR2000030054-HCQ ... IRCT20150808023559N20 IRCT20150808023559N20 NOR-Solidarity ... HC-nCoV ... Zhaowei Chen Coalition Covid-19 Brazil I ... NCT04333654 FACCT Trial Dubee Kamran
darunavir cobicistat Jun C
Emtricitabine/tenofovir plus colchicine plus rosuvastatin Gaitan-Duarte ...
Ensitrelvir (XOCOVA) Mukae - Phase 2a
favipiravir IRCT20200428047228N1 // U07 Udwadia AVIFAVIR Lou ... Chang Chen et al. NCT04310228-FAVI ... jRCTs041190120 IRCT20150808023559N20 IRCT20150808023559N20 Dabbous HM Holubar M IRCT20151227025726N14 // U07 FACCT Trial Udwadia AVIFAVIR Shenoy S NCT04542694 Ruzhentsova T Solaymani-Dodaran Shinkai
favipiravir plus interferon Khamis
hydroxychloroquine plus macrolides Duke university HCQ-AZI
azithromycin plus hydroxychloroquine ProPAC-COVID Coalition Covid-19 Brazil I ...
ivermectin Gonzalez ... Shahbaznejad Ahmed Chachar Chaccour Bukhari Kirti Babalola RIVET-COV ... Abd-Elsalam Krolewiecki I-TECH ... Mayer
ivermectin plus doxycycline Hashim A NCT04523831 ...
lopinavir/ritonavir RECOVERY SOLIDARITY ... Nojomi Ader ... ELACOI ...
lopinavir/ritonavir plus interferon ß-1a Ader ...
lopinavir/ritonavir, ribavirin and interferon beta-1b Hung et al.
niclosamide Abdulamir
nirmatrelvir / ritonavir (Paxlovid) EPIC-SR
nitazoxanide Rocco Silva Fontanesi
opaganib Winthrop
remdesivir NIH NIAID ACTT-1 DisCoVeRy ... SOLIDARITY ... Mahajan Norwegian NOR study ... Andreas ... GS-US-540-5774, 10 days GS-US-540-5774, 5 days GS-US-540-5773 ...
sofosbuvir Sali Alavi-moghaddam
sofosbuvir and daclatasvir Sadeghi Yakoot Mobarak S ... Mobarak ...
sofosbuvir and ledipasvir Elgohary Nourian A
tenofovir/emtricitabine Gaitan-Duarte ...
umifenovir (arbidol) UAIIC Nojomi ELACOI ... Yethindra ELACOI ...
zinc Patel

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons